FOLH1 and pancreatic ductal adenocarcinoma: The cytoblock preparation showed an invasive pancreatic ductal adenocarcinoma incompatible with a prostate cancer metastasis leading to the diagnosis of a PSMA positive pancreatic ductal adenocarcinoma.